ReviewPharmaceutics2026

The Inflamed Intestinal Barrier as a Formulation Variable in Oral Nanocarrier Design: Evidence-Informed Principles for Mucus Interaction, Epithelial Access, and Translational Testing.

Zofia Śledzikowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.